Recently, two cases have been referred to the Court of Justice of the European Union (“CJEU”) for a preliminary ruling on the VAT treatment of pharmaceutical companies paying rebates in a pharmaceutical supply chain.
Source Deloitte
Latest Posts in "European Union"
- Comments on ECJ C-796/23: Consideration of Czech company for VAT purposes as ‘designated partner’ in violation of EU law
- Advocate General’s Opinion Clarifies VAT Treatment of Transfer Pricing Adjustments in Stellantis Portugal Case
- Agenda of the ECJ/General Court VAT cases -1 Judgment, 1 Hearing till Feb 25, 2026
- The «Prefilling» headache
- The Fiscalis Programme 2021–2027: Interim Evaluation and Key Insights













